While fourth-quarter venture capital funding slid in most industries amid fears of an economic slowdown, biotechnology investment sprinted ahead. The question is how long the run can last.
Total U.S. venture funding reached $72.30 billion in 2015, its highest level since 2000, despite fourth-quarter investment declines in consumer services, information technology, and other markets, according to industry tracker Dow Jones VentureSource.
{iframe}http://blogs.wsj.com/venturecapital/2016/01/28/biotech-venture-investors-expect-slowdown-despite-record-2015/{/iframe}